A Study of Modified mRNA Vaccines in Healthy Adults
Conditions: SARS-CoV-2; Seasonal Influenza; Respiratory Syncytial Virus; Cytomegalovirus Interventions: Biological: mRNA-1273; Biological: mRNA-1010; Biological: mRNA-1345; Biological: FLUAD®; Biological: mRNA-1647 Sponsor: ModernaTX, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 31, 2022 Category: Research Source Type: clinical trials
Cytomegalovirus Infection After HSCT and PT-CY as GVHD Prophylaxis > > GVHD PROPHYLAXIS ERA
Condition: CMV Infection Intervention: Sponsors: Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud; Merck Sharp & Dohme Corp. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 7, 2022 Category: Research Source Type: clinical trials